ZIM LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of ZIM LABORATORIES have increased by 19.52% YoY .
The Earnings Per Share (EPS) of ZIM LABORATORIES has decreased by -29.34 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
ZIM LABORATORIES Last 5 Annual Financial Results
[BOM: 541400|NSE : ZIMLAB]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹399 Cr | ₹333 Cr | ₹307 Cr | ₹278 Cr | ₹335 Cr |
| Expenses | ₹347 Cr | ₹292 Cr | ₹268 Cr | ₹255 Cr | ₹293 Cr |
| Operating Profit (Excl OI) | ₹52 Cr | ₹41 Cr | ₹40 Cr | ₹23 Cr | ₹42 Cr |
| Other Income | ₹6.41 Cr | ₹4.40 Cr | ₹2.34 Cr | ₹4.52 Cr | ₹2.05 Cr |
| Interest | ₹5.58 Cr | ₹8.31 Cr | ₹11 Cr | ₹13 Cr | ₹11 Cr |
| Depreciation | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹14 Cr | ₹11 Cr |
| Profit Before Tax | ₹35 Cr | ₹21 Cr | ₹10 Cr | ₹0.07 Cr | ₹22 Cr |
| Profit After Tax | ₹24 Cr | ₹15 Cr | ₹7.32 Cr | ₹3.30 Cr | ₹15 Cr |
| Consolidated Net Profit | ₹24 Cr | ₹15 Cr | ₹7.32 Cr | ₹3.30 Cr | ₹15 Cr |
| Earnings Per Share (Rs) | ₹3.54 | ₹5.01 | ₹8.96 | ₹4.51 | ₹2.04 |
| PAT Margin (%) | 4.69 | 6.13 | 4.36 | 2.38 | 1.19 |
| ROE(%) | 7.86 | 13.00 | 8.65 | 4.66 | 2.17 |
| ROCE(%) | 10.11 | 16.82 | 12.52 | 8.70 | 5.39 |
| Total Debt/Equity(x) | 0.44 | 0.30 | 0.29 | 0.50 | 0.59 |
Key Financials |
||
| Market Cap | : | ₹ 534.5 Cr |
| Revenue (TTM) | : | ₹ 388.1 Cr |
| Net Profit(TTM) | : | ₹ 16.2 Cr |
| EPS (TTM) | : | ₹ 3.3 |
| P/E (TTM) | : | 33.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ZIM LABORATORIES | -3.2% | 6.2% | -2.4% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 1.7% | 45.7% |
| CIPLA | 1.7% | 0.5% | 23.7% |
| DR REDDYS LABORATORIES | 5.7% | 12.4% | 18.5% |
| ZYDUS LIFESCIENCES | -1.4% | 3.1% | 44.8% |
| DIVIS LABORATORIES | -0.1% | -2.2% | 56.9% |
| MANKIND PHARMA | 4.2% | 9.8% | 49.8% |
| TORRENT PHARMACEUTICALS | 2.2% | 10.6% | 61.7% |
| LUPIN | 4.1% | 5.1% | 71.7% |
ZIM LABORATORIES Revenues
[BOM: 541400|NSE : ZIMLAB]
| Y-o-Y | 19.52 % |
| 5 Yr CAGR | 4.41 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹399 Cr | 19.52 | |
| Mar2023 | ₹333 Cr | 8.52 | |
| Mar2022 | ₹307 Cr | 10.63 | |
| Mar2021 | ₹278 Cr | -17.18 | |
| Mar2020 | ₹335 Cr | - | |
ZIM LABORATORIES Operating Profit
[BOM: 541400|NSE : ZIMLAB]
| Y-o-Y | 26.86 % |
| 5 Yr CAGR | 5.46 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹52 Cr | 26.86 | |
| Mar2023 | ₹41 Cr | 3.06 | |
| Mar2022 | ₹40 Cr | 75.83 | |
| Mar2021 | ₹23 Cr | -46.20 | |
| Mar2020 | ₹42 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 6.10 % |
| 5 Yr CAGR | 1.00 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 13.04% | 6.10 | |
| Mar2023 | 12.29% | -5.02 | |
| Mar2022 | 12.94% | 58.97 | |
| Mar2021 | 8.14% | -35.04 | |
| Mar2020 | 12.53% | - | |
ZIM LABORATORIES Profit After Tax
[BOM: 541400|NSE : ZIMLAB]
| Y-o-Y | 67.94 % |
| 5 Yr CAGR | 12.34 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹24 Cr | 67.94 | |
| Mar2023 | ₹15 Cr | 98.82 | |
| Mar2022 | ₹7.32 Cr | 121.96 | |
| Mar2021 | ₹3.30 Cr | -78.51 | |
| Mar2020 | ₹15 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -23.49 % |
| 5 Yr CAGR | 40.90 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 4.69 % | -23.49 | |
| Mar2023 | 6.13 % | 40.60 | |
| Mar2022 | 4.36 % | 83.19 | |
| Mar2021 | 2.38 % | 100.00 | |
| Mar2020 | 1.19 % | - | |
ZIM LABORATORIES Earnings Per Share (EPS)
[BOM: 541400|NSE : ZIMLAB]
| Y-o-Y | -29.34 % |
| 5 Yr CAGR | 14.77 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹3.54 | -29.34 | |
| Mar2023 | ₹5.01 | -44.08 | |
| Mar2022 | ₹8.96 | 98.67 | |
| Mar2021 | ₹4.51 | 121.08 | |
| Mar2020 | ₹2.04 | - | |
ZIM LABORATORIES Return on Capital Employed (ROCE)
[BOM: 541400|NSE : ZIMLAB]
| Y-o-Y | -39.89 % |
| 5 Yr CAGR | 17.03 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 10.11% | -39.89 | |
| Mar2023 | 16.82% | 34.35 | |
| Mar2022 | 12.52% | 43.91 | |
| Mar2021 | 8.7% | 61.41 | |
| Mar2020 | 5.39% | - | |
ZIM LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹109.8 |
| Current MarketCap | : | ₹ 534.5 Cr |
| Updated EOD on | : | Dec 20,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZIM LABORATORIES | -3.2% |
6.2% |
-2.4% |
| SENSEX | -5% |
0.6% |
9.2% |
ZIM LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about ZIM LABORATORIES Financials
How the annual revenues of ZIM LABORATORIES have changed ?
The Revenues of ZIM LABORATORIES have increased by 19.52% YoY .
How the Earnings per Share (EPS) of ZIM LABORATORIES have changed?
The Earnings Per Share (EPS) of ZIM LABORATORIES has decreased by -29.34 % YoY .
Check out Intrinsic Value of Peers of ZIM LABORATORIES
Compare Stock Analytics of Peers of ZIM LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
